Advanced Medical Solutions Group Regulatory News (AMS)

14 September 2023

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1. Deferred Share Bonus Scheme

2. Company Share Option Plan

3. Unapproved Executive Share Option Scheme

4. Long Term Incentive Plan

5. Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2023

To:

5 September 2023

Balance of unallotted securities under scheme(s) from previous return:

1. 152,679

2. 182,253

3. 586,952

4. 274,107

5. 246,341

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 85,483

2. 40,710

3. 40,766

4. 47,585

5. Nil

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 67,196

2. 141,543

3. 546,186

4. 226,522

5. 246,341

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

Consilium Strategic Communications

Tel: +44 (0) 20 3709 5700

Matthew Neal / Lucy Featherstone

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

HSBC Bank plc (Broker)

Tel: +44 (0) 20 7991 8888

Sam McLennan / Joe Weaving / Stephanie Cornish